[1]
|
Hashimoto, R., Mukai, E., Yokomaku,-Y., Mamiya, N. and Hamaguchi, M. (2008) Clinical features and courses of 5 cases with HIV encephalopathy. Clinical Neurology, 48, 173-178.
|
[2]
|
World Health Organization. (2008) World health statistics, 13-14.
|
[3]
|
Nakashima, Y., Inoue, M. and Isse, K. (2002) Psychiatric problems of AIDS and related disorder. Japanese Journal of Clinical Psychiatry, 31,925.
|
[4]
|
Kopnisky, K.L. and Bao, J. (2007) HIV Preclinical therapeutics research: Central nervous system approaches. Journal of Neuroimmune Pharmacology, 2, 1.
|
[5]
|
Bhaskaran, K., Mussini, C., Antinori, A., Walker, A. S., Dorrucci, M., Sabin, C., Phillips, A. and Porter, K. (2008) CASCADE collaboration. Change in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretrovairal therapy. Annals of Neurology, 63, 213-221.
doi:10.1002/ana.21225
|
[6]
|
Uehira, T. and Shirasaka, T. (2001) HIV-associated cognitive-motor complex/AIDS dementia complex. Clinic All-Round, 50, 2738.
|
[7]
|
Simpson, D.M. (1999) Human immunodeficiency virus-associated dementia: Review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy. Clinical Infectious Disease, 29, 19-34.
doi:10.1086/520150
|
[8]
|
Bottiggi, K.A., Chang, J.J., Schmitt, F.A., Avison, M.J., Mootoor, Y., Nath, A. and Berger J.R. (2007) The HIV dementia scale: Predictive power in mild dementia and HAART. Journal of the Neurological Sciences, 260, 11-15. doi:10.1016/j.jns.2006.03.023
|
[9]
|
Bandaru, V.V., McArthur, J.C., Sacktor, N., Cutler, R.G., Knapp, E.L., Mattson, M.P. and Haughey, N.J. (2007) Associative and predictive biomarkers of dementia in HIV-1-infected patients. Neurology, 68, 1481-1487.
doi:10.1212/01.wnl.0000260610.79853.47
|